A PHASE 2 UMBRELLA STUDY OF RETIFANLIMAB (INCMGA00012) ALONE OR IN COMBINATION WITH OTHER THERAPIES IN PATIENTS WITH ADVANCED OR METASTATIC ENDOMETRIAL CANCER (POD1UM-204, GOG 3038, ENGOT-EN12/NOGGO) Meeting Abstract

Open Access Industry Collaboration International Collaboration

cited authors

  • Slomovitz, Brian; Monk, Bradley; Moxley, Katherine; Ghali, Nadeem; Sokol, Justyna Fronczek; Tian, Chuan; Bourayou, Nawel; Sehouli, Jalid

publication date

  • November 1, 2020

webpage

published in

category

Digital Object Identifier (DOI)

start page

  • A212

end page

  • A213

volume

  • 8